Source
EMR Claight
The sickle cell disease treatment market was valued at USD 6.29 Billion in 2025 driven by the rising prevalence of sickle cell disease and advancements in treatment options across the 8 major markets. It is expected to grow at a CAGR of 16.90% during the forecast period 2026-2035 and attain a market value of USD 29.98 Billion by 2035.